GLIDAPA TENMET 500 is a clinically advanced combination therapy formulated with Dapagliflozin 10 mg, Teneligliptin 20 mg, and Metformin Hydrochloride 500 mg (Extended Release). Marketed by Steris Healthcare Pvt. Ltd., this medication is designed to provide comprehensive blood sugar control for patients with Type 2 Diabetes Mellitus.
In India, the growing prevalence of diabetes due to sedentary lifestyle, unhealthy eating habits, and genetic predisposition has made combination therapies increasingly important. GLIDAPA TENMET 500 works through multiple mechanisms to control blood glucose levels effectively, reduce complications, and improve overall metabolic health.
This triple-drug combination offers a synergistic approach—targeting insulin resistance, glucose production, and glucose excretion—making it a preferred option for patients who require stronger glycemic control than single or dual therapy.
Uses
GLIDAPA TENMET 500 is primarily prescribed for:
Type 2 Diabetes Mellitus Management: Helps control high blood sugar levels in adults.
Improved Glycemic Control: Suitable for patients not adequately controlled with monotherapy or dual therapy.
Prevention of Diabetes Complications: Reduces the risk of long-term complications like nerve damage, kidney disease, and cardiovascular issues.
Insulin Resistance Management: Improves the body’s response to insulin.
Weight and Metabolic Control: Supports better metabolic balance in overweight diabetic patients.
Doctors often recommend this medication along with lifestyle modifications such as diet control, regular exercise, and weight management.
Benefits
1. Triple Mechanism Action
Each component of GLIDAPA TENMET 500 works differently:
Dapagliflozin: Removes excess glucose through urine by inhibiting SGLT2 in the kidneys.
Teneligliptin: Enhances insulin secretion and reduces glucagon levels.
Metformin (ER): Decreases glucose production in the liver and improves insulin sensitivity.
This multi-targeted action ensures more effective blood sugar control.
2. Effective Blood Sugar Reduction
The combination significantly lowers fasting and post-meal blood glucose levels, helping maintain stable glycemic control throughout the day.
3. Weight Management Support
Unlike some diabetes medications, Dapagliflozin may contribute to modest weight loss, making it beneficial for overweight patients.
4. Cardiovascular Protection
This combination helps reduce cardiovascular risks associated with diabetes, including heart attack and stroke.
5. Improved Patient Compliance
With three active ingredients in a single tablet, GLIDAPA TENMET 500 reduces pill burden and improves treatment adherence.
6. Extended Release Advantage
The Metformin ER (Extended Release) component ensures gradual release, minimizing gastrointestinal side effects and providing sustained glucose control.
Dosage
The dosage of GLIDAPA TENMET 500 should be strictly followed as prescribed by a healthcare professional.
Recommended Dose: Usually one tablet once daily
Administration: Take with meals to reduce stomach upset
Timing: Preferably at the same time each day
Missed Dose: Take as soon as remembered, but do not double the dose
Overdose: Seek immediate medical attention
Important Instructions
Do not crush or chew the tablet (due to extended-release formulation)
Continue medication even if you feel well unless advised otherwise
Regular monitoring of blood glucose levels is essential
Side Effects
While generally well tolerated, some patients may experience side effects:
Common Side Effects
Nausea or vomiting
Diarrhea
Frequent urination
Urinary tract infections
Headache
Moderate Side Effects
Dehydration
Dizziness
Low blood sugar (especially with other antidiabetic drugs)
Serious Side Effects (Rare)
Lactic acidosis (due to Metformin)
Severe urinary or genital infections
Kidney function impairment
If any serious symptoms occur, seek immediate medical attention. Early diagnosis helps prevent complications.
Precautions and Warnings
Before starting GLIDAPA TENMET 500, consider the following precautions:
1. Kidney Function
Patients with kidney impairment should use this medication cautiously. Regular kidney function tests are recommended.
2. Liver Disorders
Use with caution in patients with liver disease. Monitoring liver function is advised.
3. Risk of Dehydration
Dapagliflozin may increase urination, leading to dehydration. Ensure adequate fluid intake.
4. Pregnancy and Breastfeeding
Not recommended during pregnancy unless prescribed
Consult a doctor before use during breastfeeding
5. Alcohol Consumption
Avoid excessive alcohol as it increases the risk of lactic acidosis with Metformin.
6. Drug Interactions
Inform your doctor if you are taking:
Insulin or other antidiabetic drugs
Diuretics
Blood pressure medications
7. Elderly Patients
Older adults may be more sensitive to side effects, especially dehydration and kidney-related issues.
Lifestyle Tips for Better Results
To maximize the benefits of GLIDAPA TENMET 500, follow these lifestyle practices:
Maintain a balanced diabetic diet
Exercise regularly (at least 30 minutes daily)
Monitor blood glucose levels frequently
Avoid smoking and limit alcohol
Stay hydrated
Lifestyle changes play a crucial role in achieving optimal diabetes control.
Conclusion
GLIDAPA TENMET 500, containing Dapagliflozin 10 mg, Teneligliptin 20 mg, and Metformin Hydrochloride 500 mg (Extended Release), is a powerful and effective combination therapy for managing Type 2 Diabetes Mellitus. Its triple-action mechanism ensures comprehensive glycemic control, improved metabolic health, and reduced risk of long-term complications.
With added benefits like weight management support, cardiovascular protection, and improved patient compliance, this medication stands out as a reliable choice in modern diabetes care.
However, it is essential to use this medicine under proper medical supervision and combine it with a healthy lifestyle for best results. Regular monitoring and adherence to prescribed guidelines can significantly improve quality of life for diabetic patients.
